BYU Copyright Blog

JANUARY 27, 2025

Four years ago, we first published a post about an intriguing case involving two education consulting firms litigating over an online excerpt published on the website of Lehren Education (Defendant), which Ivy Coach (Plaintiff) alleged had been improperly copied, infringing on its copyrights. Lehren Education, LLC. Williams et al.

Settlement 52

Settlement Contracts Derivative Work Litigation 52

TorrentFreak

JANUARY 2, 2023

At the start of 2023, only two Malibu Media cases remain open. “Plaintiff monetizes its alleged copyrights through coercive and needless litigation and by extracting settlements from that litigation disproportionate to the minimal value of Plaintiff’s works,” the defense wrote. Last Cases Standing.

Copyright 145

Copyright Settlement Litigation Art 145

TorrentFreak

JUNE 13, 2023

The company is keeping up this pace in 2023, averaging dozens of lawsuits per week. According to some, the lawsuits’ main objective is to collect settlement payments and default judgments. . ” No Troll The argument that the company simply pursues these cases to collect settlements isn’t sufficient either. .”

Settlement 145

Settlement Copyright Copyright Infringement Privacy 145

LexBlog IP

JANUARY 20, 2023

On January 6, 2023, Genentech and Tanvex reached a settlement in principle to resolve all claims with respect to Genentech’s BCPIA complaint. The post Genentech and Tanvex Reach Settlement in Principle in Trastuzumab BPCIA Litigation appeared first on Big Molecule Watch.

Settlement 40

Settlement Litigation Reporting Patent 40

TorrentFreak

FEBRUARY 5, 2024

After settlement negotiations failed and pressure increased , DataCamp accused the plaintiffs of targeting smaller companies with copyright infringement claims, then aiming for cash settlements as an alternative to expensive lawsuits with unpredictable outcomes. Instead, DataCamp came out swinging.

Settlement 123

Settlement Copyright Infringement Copyright Intellectual Property 123

JD Supra Law

MAY 31, 2024

Copyright infringement filings continue to grow with 2023 seeing a 25% increase in cases according to year end federal court statistics.

Copyright 73

Copyright Business Settlement Copyright Infringement 73

Technology & Marketing Law Blog

MARCH 9, 2023

I’m pleased to share a draft of a new paper, “ A SAD New Category of Abusive Intellectual Property Litigation.” To that end, I am giving a couple of public talks on the paper: Tarrant County Bar Association , Texas A&M Law School, Fort Worth, TX, March 27, 2023. Free RSVP! I would welcome yours.

IP 105

IP Intellectual Property Journalism Settlement 105

TorrentFreak

FEBRUARY 11, 2023

Citing a confidential settlement agreement between the parties, the lawsuit was dismissed with prejudice , meaning that it cannot be refiled. When the plaintiffs are in the driving seat in piracy cases, settlement agreements are often used as publicity tools. Settling a legal dispute with an agreement can make perfect sense.

Settlement 109

Settlement Confidentiality Copyright Infringement Television 109

LexBlog IP

FEBRUARY 2, 2023

This installment will focus on NPE litigation as a whole, and what to expect in 2023. So where do things stand in 2023? On balance, there is a mixed bag of indicators that suggest a slight decline in NPE litigation with the same household names leading the charge. Economists are once again predicting a recession in 2023.

Litigation 40

Litigation Patent Troll Settlement Technology 40

Patently-O

NOVEMBER 27, 2023

An exotic insurance product has recently taken the litigation world by storm. 1] Now, it’s hard to avoid; a brief Internet search will turn up hundreds of hits and dozens of explainer articles by insurance brokers, law firms, and litigation funders extolling the benefits and pitching such policies to appellants.

Settlement 83

Settlement Litigation Branding Branding 83

The TTABlog

OCTOBER 21, 2024

John has kindly given me permission to provide a link to his latest effort, co-authored with his colleague, Dana Bosnic, entitled "2023-24 Trademark Developments." [pdf Latest Developments in the Effectiveness of Citing Third-Party Mark Registration and Use Evidence When Litigating Over Mark Registration Rights. pdf here ].

All Rights Reserved 49

All Rights Reserved Trademark Registration Intellectual Property 49

JD Supra Law

JANUARY 11, 2024

2023-1795 (Fed. After years of patent litigation, they entered into a settlement and license agreement. DexCom, Inc. Abbott Diabetes Care, Inc., Opinion by Stoll, joined by Dyk and Hughes. DexCom and Abbott are competing manufacturers of continuous glucose monitoring systems.

Settlement 65

Settlement Patent Licensing Litigation 65

LexBlog IP

JUNE 1, 2023

24, 2023) (Shashi H. Kewalramani), the Central District of California denied Defendant Netflix’s attempts to compel Plaintiff GoTV Streaming to provide documents and further information as to the source of the litigation funding that GoTV received in conjunction with the patent litigation. Netflix, Inc.,

Litigation 52

Litigation Licensing Settlement Patent 52

Copyright Lately

MAY 6, 2024

Copyright Termination and Loan-Out Corporations I’ve written a lot about the interplay between loan-out corporations and statutory termination under the Copyright Act, most recently in connection with a June 2023 lawsuit filed by Columbia Pictures against the writers of a story on which the Bad Boys film franchise was based.

Copyright 113

Copyright Settlement Registration Business 113

JD Supra Law

JUNE 8, 2023

On April 20, 2023, the United States Patent and Trademark Office (USPTO) announced several proposed rule changes that would have an impact on patent applicants, patent holders, and patent challengers. By: Proskauer - Minding Your Business

Settlement 59

Settlement Ownership Patent Application Litigation 59

SpicyIP

SEPTEMBER 25, 2023

Highlight of the Week Comments on the Draft Patent (Amendment) Rules, 2023 Image by rawpixel.com on Freepix Comments pertaining to transparency and on substantive proposals within the draft Patent (Amendment) Rules, 2023, submitted to the Ministry of Commerce. What’s the best way forward? Roshan Santhalia shares his perspective.

Cease and Desist 105

Cease and Desist Copyright Infringement Invention Social Media 105

The IPKat

MAY 5, 2024

Over to the team to report on Edwards Lifesciences v Meril GmbH and Meril Life Sciences ( UPC_CFI_249/2023 : "The Edwards Lifesciences v Meril preliminary injunction (PI) proceedings at the UPC on EP 3 763 331 protecting a “Prosthetic valve crimping device” (see here ) started with a bang (or should this UPCKat say, crimp?) c) and 275.2

Cease and Desist 72

Cease and Desist Settlement Reporting Litigation 72

LexBlog IP

JANUARY 19, 2024

As we settle into 2024, we reflect on the significant legal developments of 2023 that hold potential impact on the biologics and biosimilars market. The following is a recap of some of the top five legal decisions and developments in the biosimilars and biologics space in 2023 that we covered on the Big Molecule Watch. 271(e)(4)(D).

Settlement 40

Settlement Litigation Patent Reporting 40

LexBlog IP

JANUARY 16, 2024

On December 7, 2023, a group of health insurers and health insurance administrators filed a class action complaint against Johnson & Johnson and Janssen Biotech, Inc. 6,902,734, which expired on September 25, 2023, claimed the composition of ustekinumab. Stay tuned to Big Molecule Watch for more updates on this litigation.

Litigation 40

Litigation Settlement Patent Reporting 40

The IPKat

JANUARY 9, 2023

The book addresses a pressing issue at the intersection of intellectual property (IP) and investment law: how shall IP rights be treated in investor-state dispute settlement? You have until 13th January 2023. Upreti offers his answers with a focus on societal objectives of IP rights. Published: 2022 Format: Hardback Extent: 284 pp.

Intellectual Property 125

Intellectual Property IP Settlement Publishing 125

Patently-O

JANUARY 3, 2024

Court of Appeals for the Federal Circuit has begun 2023 with its first precedential patent decision in DexCom, Inc. 2023-1795 (Fed. The patentee had requested an order barring Abbott from pursuing its IPR challenges – based upon a forum selection clause that was part of a prior settlement between the parties.

Patent 64

Patent Contracts Settlement Patent Infringement 64

LexBlog IP

AUGUST 3, 2022

The Seventh Circuit issued this week a long-awaited opinion in the HUMIRA antitrust litigation, UFCW Local 1500 Welfare Fund v. AbbVie’s settlement agreements with biosimilar manufacturers provided an October 2018 market entry date for Europe and a 2023 entry date in the United States. market until 2023.”

Litigation 40

Litigation Settlement Marketing Marketing 40

LexBlog IP

MARCH 6, 2024

announced it has signed a settlement agreement with Bayer Inc. The settlement resolves multiple patent infringement proceedings in the Federal Court of Canada. In March 2023, Health Canada granted tentative approval for YESAFILI 2 mg vials, subject to resolution of any patent disputes. On March 4, Biocon Biologics Ltd.

Marketing 52

Marketing Marketing Settlement Litigation 52

Kluwer Copyright Blog

SEPTEMBER 13, 2023

Photo by Maria Oswalt on Unsplash In June 2023 the U.S. Proponents argued that the CCB would offer rightsholders a low-cost, efficient alternative to litigation in federal courts (which can easily cost over $100,000 to litigate), allowing small creators to more effectively defend their rights. million in ongoing yearly costs.

Copyright 83

Copyright Litigation Copying Journalism 83

Technology & Marketing Law Blog

OCTOBER 6, 2023

I’m sure ShutterStock would have written a $2,131 settlement check to avoid the litigation. 2, 2023) The post Photo Licensing Service Qualifies for DMCA 512(c) Safe Harbor–McGucken v. Is the attorneys’ fee shift motivating some or all of this lawsuit? Otherwise, this case appears to be economically irrational.

Licensing 98

Licensing Blogging Settlement Litigation 98

TorrentFreak

DECEMBER 26, 2022

Looking ahead to 2023, Van Voorn says that ACE will continue where it left off by adding more members in the new year. “We will also pursue litigation, where it is known to be effective in reducing piracy and increasing legitimate consumption of content,” Van Voorn concludes. Piercing the Anonymity Veil.

Cease and Desist 144

Cease and Desist Government Confidentiality Settlement 144

LexBlog IP

OCTOBER 25, 2023

As we previously reported , in July 2023 Genentech, Inc., collectively, “Genentech”) filed BPCIA litigation against Biogen MA Inc. collectively, “Genentech”) filed BPCIA litigation against Biogen MA Inc. Hoffmann-LaRoche, Inc., and Chugai Pharmaceutical Co., and Bio-Thera Solutions, Ltd.

Litigation 40

Litigation Settlement Reporting Marketing 40

Bio Law Blog

JANUARY 8, 2020

Patent litigations between biosimilar competitors of the same biologic medicine. Amgen holds the earliest launch date in the United States of any biosimilar adalimumab and will launch in January 2023. Coherus will launch in December 2023. Settlements abound and the USPTO intervenes in biosimilar IPR appeals post-settlement.

Litigation 40

Litigation Settlement Patent Patent Infringement 40

Patently-O

DECEMBER 19, 2023

Ontel successfully petitioned for Inter Partes Review (IPR) of one, US9877562, and the district court agreed to stay litigation pending outcome of the IPR. However, “mootness by reason of settlement does not justify vacatur.” Ontel Products Corp. Shaked Invs. 2022-1938 (Fed. Arizona , 520 U.S. Bancorp Mortg.

Settlement 69

Settlement Patent Patent Infringement Litigation 69

LexBlog IP

OCTOBER 19, 2021

Although approved in August 2017, CYLTEZO is not scheduled to launch until July 1, 2023, pursuant to a settlement agreement with AbbVie arising from the Humira litigation. Although several adalimumab biosimilars are scheduled to launch in 2023, CYLTEZO is the first to gain interchangeable status.

Settlement 52

Settlement Litigation Reporting Intellectual Property 52

LexBlog IP

JANUARY 25, 2024

As we kick off 2024, we reflect on regulatory developments in the biologics and biosimilars space in 2023. Below are some of the top regulatory developments from 2023. Janssen and Amgen settled their BPCIA litigation regarding Amgen’s ustekinumab biosimilar product in May 2023.

Marketing 40

Marketing Marketing Licensing Litigation 40

Technology & Marketing Law Blog

MARCH 29, 2023

Mitrakos, 22-CCB-0035 , February 15, 2023, and Oppenheimer v. Prutton, 22-CCB-0045 , February 28, 2023. Six days later, on June 17, 2023, the Respondent filed a response: In other words, the respondent acquiesced to the complainant’s requests. Prutton The second final determination was handed down on February 28, 2023.

Blogging 105

Blogging Fair Use Copyright Copyright Notice 105

Traverse Legal Blog

JULY 17, 2024

These letters, typically spearheaded by law firms known for mass litigation, can be intimidating and costly. These letters often demand quick settlements to avoid litigation. Case Overview: Citation: 2023 WL 2026994 (C.D. 14, 2023) Plaintiff: Byars Defendant: Hot Topic, Inc. Hot Topic, Inc.

Privacy 52

Privacy Litigation Business Settlement 52

LexBlog IP

MARCH 10, 2022

The announcement states that under the settlement agreement, Alvotech has non-exclusive rights to market AVT02 in the United States starting July 1, 2023. ” The announcement further states that FDA has deferred action on Alvotech’s BLA until necessary inspections are completed. .”

Patent 52

Patent Settlement Litigation Patent Infringement 52

Olartemoure Blog

AUGUST 11, 2023

On 2 August 2023, Colombia ratified the United Nations Convention on International Settlement Agreements Resulting from Mediation, also known as the Singapore Convention. The enforceability of international settlement agreements has always been an issue for companies and participants in international trade.

Settlement 52

Settlement Intellectual Property Litigation 52

Technology & Marketing Law Blog

DECEMBER 4, 2023

Applying the court’s inherent authority to punish bad faith litigation, the court concludes: “Roblox multiplied the proceedings of this case in bad faith.” The court implies that Roblox should have just accepted a low-value settlement and moved on, but Roblox has the right to adjudicate its case. Bigfinz , 2023 U.S.

Settlement 116

Settlement Blogging Trademark Law 116

IP Tech Blog

MARCH 9, 2023

When the corporation is forced to bring a lawsuit, the “little guy” infringer cries poverty and seeks a settlement. Priddis , 2023 WL 2203562 (9th Cir. 2023) (Unpub.), Priddis , 2023 WL 2203562 (9th Cir. 2023) (Unpub.). A recent Ninth Circuit decision, In Re Richard L. The case is In Re Richard L.

Settlement 57

Settlement Music Copyright Infringement Publishing 57